Position in JANX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,133,575
New position
Shares Held
269,113
first reported quarter
Ownership
0.440%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 198 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 10%
Shared 0%
None 90%
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. JANX ranks #26 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in JANX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,133,575 | 269,113 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||